Startup Creator Launched to Fill Europe's Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the goal of priming the translational pump in hot areas where European academics have already made a mark, particularly the microbiome.
Source: labiotech.eu